Dr. Lara Zibners spent two decades as an emergency pediatrician before, in her words, accidentally co-founding a women's health startup. Trained in the US and based in the UK for 20 years, she went back to school at 50 for an MBA and is now co-founder of Calla Lily Clinical Care, a British B Corp building a leak-free vaginal drug delivery platform. The idea grew out of her own experience of seven rounds of IVF and months of painful progesterone injections.

In this episode, we discuss:

• The real difference between "wellness" and "medical," and why some founders choose the wellness label to avoid regulation and reach revenue faster
• Why the traditional VC model clashes with the slow, evidence-heavy path of women's health innovation, and who is filling the gap
• Why continuous hormone monitoring can't yet tell your docto ...